This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canine Metabolic Disorder Model Development
BioVenic provides canine metabolic disorder model development services for the establishment and characterization of in vivo models of metabolic diseases affecting dogs for feed additive evaluation, nutritional research, and disease mechanism studies. Our platform covers the major canine metabolic disorders including obesity, type 1 diabetes, lipid disorders, puerperal hypocalcemia, and vitamin D deficiency. We support comprehensive model construction and validation, genetic and diet-induced modeling protocols, and biomarker evaluation spanning body fluid biochemistry, individual metabolites, and metabolomic profiling.
Background
Dogs can suffer from a range of nutritional metabolic diseases, including imbalances in carbohydrate, fat, protein, mineral, and vitamin metabolism. These disorders can arise from various causes, including genetic defects, unbalanced or excessive dietary formulations, and specific life stages such as growth spurts, lactation, or old age. Canine models used in nutritional studies are either naturally occurring or induced. These models serve as valuable tools to investigate the mechanisms underlying canine nutritional metabolic diseases, develop innovative nutritional strategies, and provide a foundation for the advancement of therapeutics for related human conditions.
Canine Metabolic Disorder Model Development
- Development of Gene-Induced Canine Metabolic Disorder Models
Certain genetic defects or mutations can render dogs more susceptible to metabolic disorders. For instance, a study by Raffan et al1 identified a mutation in POMC among Labrador retrievers prone to obesity. We provide a comprehensive range of genetic analytical tools to screen for canine metabolic disorders. Through our integrated research platform, we also offer assistance in genetic studies and the development of genetic testing technologies related to canine nutritional metabolic diseases.
Fig. 1 A POMC mutation is common in the obesity-prone Labrador retriever1,2
- Development of Diet-Induced Canine Metabolic Disorder Models
By employing specific feeding methods such as unlimited access to food or customized diets (e.g., high-fat diet), researchers can induce models of canine obesity. Our solutions encompass the development of diet-induced canine nutrient metabolic disorder models. We can propose suitable induction protocols based on your requirements and previous research, conduct testing services for induced feeds, and provide assistance in constructing models that simulate nutrient deficiencies or over-nutrition-induced canine metabolic disorders.
- Evaluation of Biomarkers in Canine Metabolic Disorder Models
Assessing changes in metabolic pathways and biomarkers with potential clinical utility in canine metabolic disorder models is crucial. Not only does it shed light on the nutritional physiology of dogs, but it also provides valuable information for human nutrition. Our services include assays for body fluid biochemical markers, individual metabolites, or metabolomic profiling to evaluate your canine metabolic disorder model.
- For further information, please visit our sections.
Common Metabolic Disorders in Dogs
| Metabolic Disorders | Causes | Indicators |
|---|---|---|
| Obesity | Genetic (breed-related predisposition) and environmental (insufficient exercise, neutering, etc.), energy intake exceeding energy expenditure. |
|
| Type 1 diabetes | Insulin-secreting cells in the pancreas are destroyed, resulting in an absolute lack of insulin. |
|
| Lipid disorders | Primary (genetic) and secondary (diet, diabetes, endocrine diseases, etc.). |
|
| Puerperal hypocalcemia | Loss of calcium into the milk and too little calcium in the diet. |
|
| Vitamin D deficiency | Unbalanced diets |
|
Related Research
In a comprehensive review examining the role of leptin in canine obesity and its associated metabolic disorders, the immunological and endocrine profiles of obese dogs were systematically characterized. Canine obesity was shown to induce hyperleptinemia and leptin resistance, paralleling the human metabolic syndrome phenotype, with elevated circulating cytokines (TNF-α, IL-6) and inflammatory markers confirming chronic low-grade inflammation. The review detailed how leptin dysregulation in obese dogs disrupts insulin signaling, promotes pancreatic inflammation, alters cardiac mitochondrial metabolism leading to cardiovascular dysfunction, and increases susceptibility to orthopedic disorders and neoplasia. Immune cell profiling revealed that obesity-associated leptin resistance impairs natural killer cell function and skews T-cell polarization toward pro-inflammatory Th1 responses. This work establishes the obese dog as a translational model for human metabolic syndrome, demonstrating that spontaneous canine obesity recapitulates the key endocrine, immune, and inflammatory pathways driving metabolic disease progression.
Fig. 2 Obesity in dogs and diseases associated with hyperleptinemia.1,3
Applications of Canine Metabolic Disorder Models
- Evaluation of Canine Nutritional Strategies
Canines in specific metabolic states require tailored nutrition. The development of canine nutritional and metabolic disorder models enables customers to conduct experiments on feed formulations, nutritional additives, and feeding methods, among others. This facilitates the identification of suitable nutritional strategies for dogs with metabolic disorders.
- Exploration of Mechanisms in Canine Metabolic Disorders
With the help of our analyzing platform, clients can delve into the mysteries surrounding canine nutritional metabolic disorders. This expands your understanding of the underlying mechanisms involved, ultimately supporting the welfare and health of dogs.
- Prevention and Treatment Development for Canine Metabolic Disorders
By utilizing an untargeted metabolomics approach, the study of nutritional metabolic disorders in both model and normal dogs allows for the identification of differential metabolites from a molecular perspective. This information can serve as a reference for the prevention and management of metabolic disorders.
- Development of Therapies for Humans
As many genetic diseases in dogs have human counterparts, dogs are considered valuable large animal models in human biomedicine. The canine model has played a pivotal role in the early development of various diabetes therapies, including techniques for pancreatic islet transplantation and immunosuppressive protocols.
Why Choose Us?
As enthusiasts of dogs, we possess a profound knowledge of their physiological characteristics and nutritional requirements. We are delighted to offer our assistance in canine nutrition research.
Our extensive range of testing products and services specifically designed for dogs ensures a dependable testing platform that can cater to your needs.
We are committed to comprehending your research requirements for the development of canine nutritional metabolic models and providing prompt responses to meet your expectations.
The requests and privacy of our clients hold great significance to us, and we maintain strict confidentiality for all our research programs.
Case Study: Validation of a Diet-Induced Obesity & Insulin-Resistance Model in Dogs
Objective: A pet-nutrition client needed independent confirmation that their high-fat-diet induced canine obesity and insulin-resistance model had been successfully established before evaluating a weight-management nutraceutical. BioVenic provided a model-validation service: the client shipped matched serum samples from model and healthy-control dogs, and BioVenic ran a standardized ELISA + biochemical panel to verify the disease phenotype.
Animals: Dogs assigned to a Model group (high-fat-diet induction protocol) and a Healthy Control group (balanced diet).
Samples provided by client: Fasting serum collected at study endpoint.
BioVenic validation panel: Serum glucose, insulin, leptin, and lipid profile (triglycerides, total cholesterol) by ELISA/microplate biochemistry; liver enzymes (ALT) and adipokine profiling as supportive readouts.
Fig. 3 Validation of Biomarkers in a Canine Model
Frequently Asked Questions
Q1: Which canine metabolic disorders can BioVenic model, and why use dogs?
A: We model obesity, type 1 diabetes, lipid disorders, puerperal hypocalcemia, and vitamin D deficiency. Dogs are valuable because many canine genetic metabolic diseases have human counterparts and their physiology closely mirrors humans—canine models have informed diabetes therapies including islet transplantation—making them strong translational large-animal models.
Q2: What induction approaches do you use for canine models?
A: We offer both gene-induced and diet-induced models. Genetic approaches include screening for metabolic-disorder-associated mutations (e.g., POMC) and developing genetic-testing tools via our integrated platform. Diet-induced models use customized protocols such as high-fat diet or ad libitum feeding to simulate over-nutrition or nutrient-deficiency states; we propose induction protocols, test induced feeds, and support model construction.
Q3: How do you validate canine models and measure biomarkers?
A: Validation tracks phenotype (body weight versus ideal, visual condition), blood biochemistry (glucose, insulin, cholesterol, triglycerides, calcium, 25-hydroxyvitamin D), and metabolomic profiling (LC-MS/MS, GC-MS) to reveal differential metabolites. These readouts illuminate canine nutritional physiology and inform both canine health and human nutrition research.
Q4: What deliverables and applications does the service support?
A: You receive the custom diet, the established and validated model, and biomarker or metabolomics reports. Applications include evaluating canine nutritional strategies (feed formulations, additives, feeding methods), exploring disease mechanisms, developing prevention and treatment approaches, and—leveraging the human–canine disease overlap—advancing therapies for corresponding human conditions.
Our expertise lies in the field of animal nutrition research products and services, with a dedicated focus on delivering comprehensive metabolic disorder model development programs for researchers in canine nutrition. BioVenic's canine metabolic disorder model development service can meet your research needs for model development, optimization and validation. It also has a wide range of applications in canine nutrition, drug and therapy development. If our services resonate with your interests, please don't hesitate to contact us.
References
- Distributed under Open Access license CC BY 4.0.
- Raffan, Eleanor, et al. "A deletion in the canine POMC gene is associated with weight and appetite in obesity-prone labrador retriever dogs." Cell metabolism 23.5 (2016): 893-900. https://doi.org/10.1016/j.cmet.2016.04.012. The title was changed to "A POMC mutation is common in the obesity-prone Labrador retriever".
- Cortese, Laura, Giuseppe Terrazzano, and Alessandra Pelagalli. "Leptin and immunological profile in obesity and its associated diseases in dogs." International journal of molecular sciences 20.10 (2019): 2392. https://doi.org/10.3390/ijms20102392. Without Modification.